These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23852539)

  • 1. An endogenously produced fragment of cardiac myosin-binding protein C is pathogenic and can lead to heart failure.
    Razzaque MA; Gupta M; Osinska H; Gulick J; Blaxall BC; Robbins J
    Circ Res; 2013 Aug; 113(5):553-61. PubMed ID: 23852539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro.
    Govindan S; Sarkey J; Ji X; Sundaresan NR; Gupta MP; de Tombe PP; Sadayappan S
    J Muscle Res Cell Motil; 2012 May; 33(1):17-30. PubMed ID: 22527638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMI-0100 Inhibits Cardiac Fibrosis in a Mouse Model Overexpressing Cardiac Myosin Binding Protein C.
    Meng Q; Bhandary B; Osinska H; James J; Xu N; Shay-Winkler K; Gulick J; Willis MS; Lander C; Robbins J
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28871043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72.
    Ham YM; Mahoney SJ
    Exp Cell Res; 2013 Jun; 319(10):1451-62. PubMed ID: 23567182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background.
    Sadayappan S; Gulick J; Klevitsky R; Lorenz JN; Sargent M; Molkentin JD; Robbins J
    Circulation; 2009 Mar; 119(9):1253-62. PubMed ID: 19237661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice.
    Liu Y; Shen Y; Zhu J; Liu M; Li X; Chen Y; Kong X; Song G; Qian L
    Cell Physiol Biochem; 2015; 35(5):1975-85. PubMed ID: 25871431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Multi-Scale Cardiac Architecture in Association With Phosphorylation of Myosin Binding Protein-C.
    Taylor EN; Hoffman MP; Barefield DY; Aninwene GE; Abrishamchi AD; Lynch TL; Govindan S; Osinska H; Robbins J; Sadayappan S; Gilbert RJ
    J Am Heart Assoc; 2016 Mar; 5(3):e002836. PubMed ID: 27068630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway.
    Murray J; Huss JM
    Am J Physiol Cell Physiol; 2011 Sep; 301(3):C630-45. PubMed ID: 21562305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U0126 attenuates ischemia/reperfusion-induced apoptosis and autophagy in myocardium through MEK/ERK/EGR-1 pathway.
    Wang A; Zhang H; Liang Z; Xu K; Qiu W; Tian Y; Guo H; Jia J; Xing E; Chen R; Xiang Z; Liu J
    Eur J Pharmacol; 2016 Oct; 788():280-285. PubMed ID: 27343376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere.
    Cheng Y; Wan X; McElfresh TA; Chen X; Gresham KS; Rosenbaum DS; Chandler MP; Stelzer JE
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H52-65. PubMed ID: 23666674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
    Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
    J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition.
    Münzel F; Mühlhäuser U; Zimmermann WH; Didié M; Schneiderbanger K; Schubert P; Engmann S; Eschenhagen T; Zolk O
    Cardiovasc Res; 2005 Dec; 68(3):464-74. PubMed ID: 16040022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myofibroblast-Specific TGFβ Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy.
    Meng Q; Bhandary B; Bhuiyan MS; James J; Osinska H; Valiente-Alandi I; Shay-Winkler K; Gulick J; Molkentin JD; Blaxall BC; Robbins J
    Circ Res; 2018 Dec; 123(12):1285-1297. PubMed ID: 30566042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.
    Flagg TP; Cazorla O; Remedi MS; Haim TE; Tones MA; Bahinski A; Numann RE; Kovacs A; Schaffer JE; Nichols CG; Nerbonne JM
    Circ Res; 2009 Jan; 104(1):95-103. PubMed ID: 19023131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
    Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
    J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Ghrelin Intervention on the Ras/ERK Pathway in the Regulation of Heart Failure by PTEN.
    Zhao Y; Sun Q; Xu Z; Li M; Tian G
    Comput Math Methods Med; 2022; 2022():1045681. PubMed ID: 35082908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period.
    Cannon L; Yu ZY; Marciniec T; Waardenberg AJ; Iismaa SE; Nikolova-Krstevski V; Neist E; Ohanian M; Qiu MR; Rainer S; Harvey RP; Feneley MP; Graham RM; Fatkin D
    J Am Coll Cardiol; 2015 Feb; 65(6):560-9. PubMed ID: 25677315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.
    Lombardi R; Rodriguez G; Chen SN; Ripplinger CM; Li W; Chen J; Willerson JT; Betocchi S; Wickline SA; Efimov IR; Marian AJ
    Circulation; 2009 Mar; 119(10):1398-407. PubMed ID: 19255346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of heart-specific small subunit of myosin light chain phosphatase results in heart failure and conduction disturbance.
    Arimura T; Muchir A; Kuwahara M; Morimoto S; Ishikawa T; Du CK; Zhan DY; Nakao S; Machida N; Tanaka R; Yamane Y; Hayashi T; Kimura A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1192-H1202. PubMed ID: 29451818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.